BMO Hosts Second Annual Obesity Summit on the Future of the GLP-1+ Market [Yahoo! Finance]
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Last corbus pharmaceuticals holdings, inc. earnings: 3/12 07:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
corbuspharma.com
Company Research
Source: Yahoo! Finance
NEW YORK March 18, 2025 /CNW/ - Join BMO and industry leaders in New York on March 25 for the BMO 2025 Obesity Summit to discuss the growing $150 billion obesity therapies market. The Summit features an exciting line-up of leaders in the space as well as next generation players from Altimmune, Amgen, Corbus Pharmaceuticals and Eli Lilly, to FlyteHealth, Novo Nordisk, Roman Health, Scholar Rock and Structure Therapeutics. Participants will focus on the advances in GLP-1 drug therapies and feature expert insights from pharmacy benefit managers, patients, and providers to help identify and discuss the opportunities and challenges in this market. What: 2025 BMO Obesity Summit When: Tuesday, March 25, 2025 Where: Convene, 360 Madison Ave, New York Media: Register here The BMO Obesity Summit will deliver thought leadership and corporate management perspectives in a variety of formats such as fireside chats, expert panels and presentations, including: Discussions with le
Show less
Read more
Impact Snapshot
Event Time:
CRBP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRBP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRBP alerts
High impacting Corbus Pharmaceuticals Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
CRBP
News
- Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Phase 1a Single-Ascending and Multiple-Ascending Dose Data Transcript [Seeking Alpha]Seeking Alpha
- Corbus Pharmaceuticals (NASDAQ:CRBP) had its price target lowered by analysts at Royal Bank Of Canada from $55.00 to $53.00. They now have an "outperform" rating on the stock.MarketBeat
- Corbus Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides a Corporate UpdateGlobeNewswire
- Corbus Pharmaceuticals to Participate in Upcoming Investor ConferencesGlobeNewswire
- Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window [Seeking Alpha]Seeking Alpha
CRBP
Earnings
- 11/12/25 - Miss
CRBP
Sec Filings
- 12/18/25 - Form 8-K
- 12/15/25 - Form SCHEDULE
- 12/15/25 - Form 4
- CRBP's page on the SEC website